Janux Therapeutics

$14.71 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Janux Therapeutics

Janux Therapeutics, Inc. operates as a biotech company. The Company offers immunotherapies for cancer patients that direct their immune system to eradicate tumors to overcome their diseases as well as provides testing services. Janux Therapeutics serves customers worldwide.

Stock Analysis

last close $14.76
1-mo return -26.3%
3-mo return -30.5%
avg daily vol. 99.58T
52-week high 37.99
52-week low 14.08
market cap. $656M
forward pe -
annual div. -
roe -
ltg forecast 13.8%
dividend yield -
annual rev. $1M
inst own. 83.1%
baraka

Subscribe now for daily local and international financial news

Subscribe